Connection

Jacqueline Kraveka to Dacarbazine

Back to Details
This is a "connection" page, showing publications Jacqueline Kraveka has written about Dacarbazine.
Jacqueline Kraveka
Connection Strength
0.128
Dacarbazine
  1. A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma. Pediatr Blood Cancer. 2016 Jan; 63(1):39-46.
    View in: PubMed
    Score: 0.128
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.